[Effects of drugs used in high-risk pregnancy on child development].
The study involved 60 children delivered by the mothers of risk group who were given gestagens and beta-adrenomimetics during pregnancy. Physical, motoric development and morbidity in this group of children with particular relation to respiratory diseases were subject to our study. Thirty eight children delivered by healthy mothers were used as a control group. It was found that there was no developmental abnormalities in children from pregnancies maintained with gestagens and beta-adrenomimetics. Morbidity rate was the same in the tested and control groups.
Brodzikowska-Pytel
A
A
II Kliniki Chorób Dzieci AM w Gdańsku.
Janowiak
Z
Z
Liberek
A
A
Majkowska-Bonarowska
K
K
Sadkiewicz
G
G
D000500:Allylestrenol / Q000627:therapeutic use*; D002648:Child; D002657:Child Development / Q000187:drug effects* / Q000502:physiology; D002675:Child, Preschool; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use*; D006128:Growth / Q000187:drug effects*; D006801:Humans; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D015149:Tocolytic Agents / Q000627:therapeutic use*
D015149:Tocolytic Agents; D005280:Fenoterol; D000500:Allylestrenol
Wpływ leków stosowanych u kobiet w ciazy ryzyka na dalszy rozwój dzieci.